GALAD Score for the Diagnosis of Hepatocellular Carcinoma in Sub-Saharan Africa: A Validation Study in Ghanaian Patients
Authors:
- Yvonne Ayerki NarteyYNYvonne Ayerki Nartey
- Ju Dong YangJYJu Dong Yang
- Tyler J. ZemlaTZTyler J. Zemla
- Joshua AyawinJAJoshua Ayawin
- Shadrack Osei AsibeySAShadrack Osei Asibey
- Mohamed El-KassasMEMohamed El-Kassas
- Sally Afua BampohSBSally Afua Bampoh
- Amoako DuahADAmoako Duah
- Adwoa Agyei-NkansahAAAdwoa Agyei-Nkansah
- Yaw Asante AwukuYAYaw Asante Awuku
- Mary Yeboah AfiheneMAMary Yeboah Afihene
- Hiroyuki YamadaHYHiroyuki Yamada
Open Access
- 1 October 2024
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research Communications
- Vol. 4 (10) , 2653-2659
Abstract
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related mortality worldwide including sub-Saharan Africa. The GALAD score, derived from Gender, Age, Lens culinaris agglutinin-reactive fraction of alpha fetoprotein, Alpha fetoprotein, and Des-carboxy-prothrombin, has high accuracy in diagnosing HCC in Asia, Europe, and North America; however, it has not been validated in an African cohort. The aim of this study was to assess the performance of the GALAD score in the diagnosis of HCC in sub-Saharan Africa. Clinical data from patients with cirrhosis (n = 93) or HCC (n = 78) from outpatient hepatology clinics at three teaching hospitals in Ghana were abstracted, and serum samples were analyzed. A logistic regression model predicting HCC status based on the GALAD score was constructed to obtain the ROC curve for GALAD. The AUC with 95% confidence interval (CI) was calculated. The median GALAD score was higher among patients with HCC versus cirrhosis controls (8.0 vs. −4.1, P < 0.01). The AUC of the GALAD score for HCC detection was 0.86 (95% CI, 0.79–0.92). At a cut-off value of −0.37, the GALAD score had a sensitivity of 0.81 and a specificity of 0.86. The AUC (95% CI) was 0.87 (0.80–0.95) and 0.81 (0.67–0.94) in hepatitis B virus–positive and hepatitis B virus–negative patients, respectively. The GALAD score has a high accuracy for HCC detection. It has great potential to improve HCC surveillance in sub-Saharan Africa where imaging resources are limited. Significance: The GALAD score or its relevant modifications have the potential to aid in improving HCC surveillance efforts in low-resource settings in sub-Saharan Africa. This could enhance early detection rates of HCC and potentially improve survival rates in resource-limited settings.Keywords
All Related Versions
This publication has 31 references indexed in Scilit:
- Liver ultrasound in cirrhosis is inadequate for hepatocellular carcinoma surveillance compared to magnetic resonance imagingLiver Cancer International, 2022
- HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis: A meta-analysisJournal of Hepatology, 2022
- The Performance of AFP, AFP-3, DCP as Biomarkers for Detection of Hepatocellular Carcinoma (HCC): A Phase 3 Biomarker Study in the United StatesClinical Gastroenterology and Hepatology, 2022
- Validation of a Novel Multitarget Blood Test Shows High Sensitivity to Detect Early Stage Hepatocellular CarcinomaClinical Gastroenterology and Hepatology, 2022
- GALAD Score Detects Early Hepatocellular Carcinoma in an International Cohort of Patients With Nonalcoholic SteatohepatitisClinical Gastroenterology and Hepatology, 2020
- Surveillance and Diagnosis of Hepatocellular CarcinomaClinical Liver Disease, 2019
- AASLD guidelines for the treatment of hepatocellular carcinomaHepatology, 2017
- Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in PatientsClinical Gastroenterology and Hepatology, 2016
- Factors That Affect Accuracy of α-Fetoprotein Test in Detection of Hepatocellular Carcinoma in Patients With CirrhosisClinical Gastroenterology and Hepatology, 2014
- EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinomaJournal of Hepatology, 2012